Alejandro Bravo‐Cuéllar

1.7k total citations
92 papers, 1.4k citations indexed

About

Alejandro Bravo‐Cuéllar is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Alejandro Bravo‐Cuéllar has authored 92 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 26 papers in Immunology and 18 papers in Oncology. Recurrent topics in Alejandro Bravo‐Cuéllar's work include Cell death mechanisms and regulation (12 papers), Immune Cell Function and Interaction (11 papers) and NF-κB Signaling Pathways (7 papers). Alejandro Bravo‐Cuéllar is often cited by papers focused on Cell death mechanisms and regulation (12 papers), Immune Cell Function and Interaction (11 papers) and NF-κB Signaling Pathways (7 papers). Alejandro Bravo‐Cuéllar collaborates with scholars based in Mexico, France and United States. Alejandro Bravo‐Cuéllar's co-authors include Pablo Cesar Ortiz‐Lazareno, Georgina Hernández‐Flores, Luis Felipe Jave‐Suárez, Adriana Aguilar‐Lemarroy, Susana del Toro‐Arreola, José Manuel Lerma-Díaz, Jorge Ramiro Domínguez-Rodríguez, Adrián Daneri‐Navarro, S. Orbach‐Arbouys and Martha Cecilia Téllez‐Bañuelos and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Molecular Cancer.

In The Last Decade

Alejandro Bravo‐Cuéllar

85 papers receiving 1.4k citations

Peers

Alejandro Bravo‐Cuéllar
Alejandro Bravo‐Cuéllar
Citations per year, relative to Alejandro Bravo‐Cuéllar Alejandro Bravo‐Cuéllar (= 1×) peers Pablo Cesar Ortiz‐Lazareno

Countries citing papers authored by Alejandro Bravo‐Cuéllar

Since Specialization
Citations

This map shows the geographic impact of Alejandro Bravo‐Cuéllar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Bravo‐Cuéllar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Bravo‐Cuéllar more than expected).

Fields of papers citing papers by Alejandro Bravo‐Cuéllar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Bravo‐Cuéllar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Bravo‐Cuéllar. The network helps show where Alejandro Bravo‐Cuéllar may publish in the future.

Co-authorship network of co-authors of Alejandro Bravo‐Cuéllar

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro Bravo‐Cuéllar. A scholar is included among the top collaborators of Alejandro Bravo‐Cuéllar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro Bravo‐Cuéllar. Alejandro Bravo‐Cuéllar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hernández‐Flores, Georgina, et al.. (2024). Improvement of Docetaxel Efficacy through Simultaneous Blockade of Transcription Factors NF-κB and STAT-3 Using Pentoxifylline and Stattic in Prostate Cancer Cells. Current Issues in Molecular Biology. 46(9). 10140–10159. 1 indexed citations
2.
Ortiz‐Lazareno, Pablo Cesar, et al.. (2023). Pentoxifylline Inhibits TNF-α/TGF-β1-Induced Epithelial-Mesenchymal Transition via Suppressing the NF-κB Pathway and SERPINE1 Expression in CaSki Cells. International Journal of Molecular Sciences. 24(13). 10592–10592. 10 indexed citations
3.
Téllez‐Bañuelos, Martha Cecilia, Georgina Hernández‐Flores, Alejandro Bravo‐Cuéllar, et al.. (2020). Differential effects of alliin and allicin on apoptosis and senescence in luminal A and triple‐negative breast cancer: Caspase, ΔΨm, and pro‐apoptotic gene involvement. Fundamental and Clinical Pharmacology. 34(6). 671–686. 29 indexed citations
4.
Bravo‐Cuéllar, Alejandro, et al.. (2020). Fulminant Hepatitis Managed with Pentoxifylline. Clinical and Experimental Pharmacology. 10(1). 1–5. 1 indexed citations
5.
Hernández‐Flores, Georgina, Pablo Cesar Ortiz‐Lazareno, Erick Sierra‐Díaz, et al.. (2018). Regulation of immunophenotype modulation of monocytes-macrophages from M1 into M2 by prostate cancer cell-culture supernatant via transcription factor STAT3. Immunology Letters. 196. 140–148. 39 indexed citations
6.
Sánchez-Reyes, Karina, Georgina Hernández‐Flores, Alejandro Bravo‐Cuéllar, et al.. (2016). Culture supernatants of cervical cancer cells induce an M2 phenotypic profile in THP-1 macrophages. Cellular Immunology. 310. 42–52. 41 indexed citations
7.
Piña‐Sánchez, Patricia, et al.. (2016). HOXA9 is Underexpressed in Cervical Cancer Cells and its Restoration Decreases Proliferation, Migration and Expression of Epithelial-to-Mesenchymal Transition Genes. Asian Pacific Journal of Cancer Prevention. 17(3). 1037–1047. 24 indexed citations
8.
Hernández‐Flores, Georgina, et al.. (2012). Efectos del cambio climático en la salud. 63(4). 8–17. 2 indexed citations
9.
Jave‐Suárez, Luis Felipe, Pablo Cesar Ortiz‐Lazareno, Alejandro Bravo‐Cuéllar, et al.. (2012). Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications. BMC Immunology. 13(1). 7–7. 21 indexed citations
10.
Meza‐Canales, Ivan D., Pablo Cesar Ortiz‐Lazareno, Georgina Hernández‐Flores, et al.. (2012). Peripheral T-lymphocytes express WNT7A and its restoration in leukemia-derived lymphoblasts inhibits cell proliferation. BMC Cancer. 12(1). 60–60. 18 indexed citations
11.
Aguilar‐Lemarroy, Adriana, Carmen Magdalena Gurrola‐Díaz, Georgina Hernández‐Flores, et al.. (2011). MEIS1, PREP1, and PBX4 Are Differentially Expressed in Acute Lymphoblastic Leukemia: Association of MEIS1 Expression with Higher Proliferation and Chemotherapy Resistance. Journal of Experimental & Clinical Cancer Research. 30(1). 112–112. 24 indexed citations
12.
Bravo‐Cuéllar, Alejandro, et al.. (2009). La pentoxifilina en la hepatitis fulminante: Reporte de dos casos. 20(1). 33–39. 2 indexed citations
13.
Bravo‐Cuéllar, Alejandro, et al.. (2007). [Comparison of two types of anesthesia on plasma levels of inflammatory markers].. PubMed. 75(2). 99–105. 14 indexed citations
14.
Hernández‐Flores, Georgina, et al.. (2007). La creatinfosfokinasa tiene utilidad en la evaluación pronóstica temprana de discapacidad en el infarto cerebral. Revista Ecuatoriana de Neurologia. 16(2). 97–102.
15.
Bravo‐Cuéllar, Alejandro, et al.. (2004). Estudio preliminar con el uso de barras de teflón (PTFE, politetrafluoretileno) perforado en la parálisis unilateral de las cuerdas vocales. 49(3). 53–59.
16.
Vásquez‐Garibay, Edgar M., et al.. (2000). The Amikacin on premature newborn: schema of treatment defined by gestational and postnatal age.. 11(4). 251–256. 1 indexed citations
17.
Bravo‐Cuéllar, Alejandro, et al.. (1992). The bactericidal capacity of peripheral blood monocytes from HIV positive patients may collapse very soon after the infection. Immunology Letters. 31(3). 297–299. 11 indexed citations
18.
Balercia, Giancarlo, et al.. (1990). Allo‐activated CD4+ and CD8+ lymphocyte subsets: New ultrastructural findings based on computer‐assisted image analysis. European Journal Of Haematology. 44(3). 179–185. 2 indexed citations
19.
Bravo‐Cuéllar, Alejandro, et al.. (1989). Enhanced activity of peritoneal cells after aclacinomycin injection: effect of pretreatment with superoxide dismutase on aclacinomycin-induced cytological alterations and antitumoral activity.. PubMed. 49(6). 1578–86. 9 indexed citations
20.
Bravo‐Cuéllar, Alejandro, et al.. (1989). In vivo immunopharmacological properties of the traditional Chinese medicine Kang Fu-Xin (KFX). 5(1). 25–33. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026